ENTITY
Vertex Pharmaceuticals

Vertex Pharmaceuticals (VRTX US)

103
Analysis
Health Care • United States
Vertex Pharmaceuticals Incorporated discovers, develops, and commercializes novel, small molecule pharmaceuticals for the treatment of diseases for which there are currently limited or no effective treatments. The Company develops drugs for the treatment of cystic fibrosis, autoimmune diseases, cancer, inflammatory bowel disease, and neurological disorders.
more
Exchange Announcement • 02 Sep 2026 04:25

Current Report (Form 8-K | Period ending 2026-08-27)

Exchange Announcement • 04 Aug 2026 08:00

Quarterly Report (Form 10-Q | Period ending 2026-06-30)

Exchange Announcement • 14 May 2026 04:07

S-8 | Initial registration statement for securities to be offered to employees pursuant to employee benefit plans

Exchange Announcement • 14 May 2026 04:03

Current Report (Form 8-K | Period ending 2026-05-13)

Exchange Announcement • 05 May 2026 08:00

Quarterly Report (Form 10-Q | Period ending 2026-03-31)

x